If you took Actos and developed bladder cancer, heart failure
or other serious complications, you have legal options.
Actos, a Type 2 diabetes medication has been linked to a number of ailments and has been indicated as a cause of death. A 2010 study showed that the Avandia alternative is as dangerous as the drug that it replaced and is linked to ailments such as congestive heart failure, heart disease, kidney and liver damage, bone fracture, and higher risk of getting bladder cancer. Although the maker of Actos said that based on a 10-year study the drug did not increase bladder cancer risk, it has been found that those who used the drug for a period of 2 years faced risk of getting bladder-related cancer.
If you, or a loved one, developed bladder cancer while taking Actos you may be entitled to a cash settlement. Please complete the form and one of our attorneys will contact you - or call 1-800-LAW-FIRM now.
In June 2011, the Food & Drug Administration reviewed the drug for possible bladder cancer risk. Another study was done a month before the FDA took action and results show that those who have been taking Actos face a lopsided risk of getting bladder cancer. It is important to note however that the drug has already been banned in France and Germany after the French Medicines Agency found that patients taking Actos had a 22% higher rate of getting bladder cancer with those receiving an overall dosage of 28, 000 mg for a certain period more prone to the disease. New research has been done regarding the risks of taking Actos and it has been noted that the Type 2 diabetes drug also causes heart attack, cardiovascular disease, and death at a rate of 30% or even higher. Although the above-mentioned risks are already reason enough for patients using the medication distributed by Takeda Pharmaceuticals to stop taking it, another recent study published in the Journal of Clinical Endocrinology & Metabolism showed that Actos causes increased risk of fractures. Postmenopausal women are the most vulnerable in this case and should refrain from taking Actos. Because of the different studies done by different organizations in the United States and abroad, the debate over the safety of Actos as a Type 2 diabetes drug still ensues. The FDA however has required Takeda Pharmaceuticals to put a black box warning on the label.
Lawsuits against Takeda Pharmaceuticals have been consolidated in Illinois state court, and in federal multidistrict litigation in Louisiana: